Developer docs
API playgroundTry for free, no card

Search company profiles

Dosis

Full company profile

uuid00077yg

Namestring
Dosis
Websiteurl
dosisinc.com
Company typeenum
Private
Founded yearint
2017
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
AI dosing platform, personalized medication dosing, clinical decision support, healthcare AI software, drug dose optimization
Industry2 codes
1Medication Safety, Dosing & Drug Interaction CDS
CodeHLACAGABPrimaryYes
2Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools
CodeHLACAKAHPrimaryNo
NAICS code1 code
  • Other Ambulatory Health Care Services6219
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Decision Support Software
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Dosis sells an AI-powered personalized dosing platform intended for healthcare providers to determine individualized medication doses for patients. The platform replaces or augments standard dosing protocols with AI-driven, patient-specific dose recommendations as a clinical decision-support software tool.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Dosis AI Personalized Dosing Platform
CategoryClinical Decision Support Software
Description

An AI-powered software platform that provides personalized, patient-specific medication dose recommendations to healthcare providers, supporting clinical decision-making in drug dosing.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers8 records
1Arine
TypeEmerging player
Description

Arine applies AI to medication optimization and adherence for value-based care populations. It overlaps with Dosis on data-driven medication management but operates at the regimen/therapy level rather than per-dose decision support.

2Health Catalyst
TypeOthers
Description

Health Catalyst is a healthcare data and analytics platform that increasingly embeds clinical improvement applications, including medication-related use cases. It is an adjacent data/analytics peer rather than a direct dosing competitor.

3DoseMe
TypeDirect peer
Description

DoseMeRx (formerly DoseMe) provides Bayesian-model-based individualized dosing software for hospitals and pharmacists, targeting similar therapeutic areas (e.g., vancomycin, aminoglycosides). It directly competes with Dosis's personalized dosing proposition.

4InsightRX
TypeDirect peer
Description

InsightRX is a precision-dosing clinical decision support platform that uses Bayesian and ML models to individualize drug dosing for clinicians. It is the closest direct competitor to Dosis in AI-driven personalized dosing.

5First Databank (FDB)
TypeOthers
Description

FDB supplies drug knowledge bases (including dosing and interaction data) that power EHRs and CDS systems worldwide. It is an ecosystem enabler and indirect competitor whose content underpins many dosing workflows Dosis targets.

6Wolters Kluwer (Medi-Span / UpToDate Lexidrug)
TypeOthers
Description

Wolters Kluwer provides clinical drug information, including dosing guidance, integrated into provider workflows. It is an enabling/adjacent player whose dosing content competes for the same evidence-based decision moment.

7Tabula Rasa HealthCare
TypeBroad incumbent
Description

Tabula Rasa (now part of ExactCare) combines proprietary pharmacogenomics and dosing science with pharmacy services to optimize medication regimens for at-risk patients. It is a broader, more established incumbent in medication safety and dosing.

8Renalytix
TypeEmerging player
Description

Renalytix applies AI-driven diagnostics and prognostic tools to kidney disease, overlapping with Dosis on the CKD patient population and value-based nephrology contracting — though Renalytix focuses on risk prediction rather than dosing.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dosis

Clinical Decision Support Softwaredosisinc.com

Dosis firmographics

Firmographics
Name
Dosis
Website
https://dosisinc.com
Company type
Private
Founded year
2017
Headcount range
1–10 employees
Ownership category
akta.pro rank

Dosis industry classification

Industry
Product category
Clinical Decision Support Software
NAICS
Other Ambulatory Health Care Services (6219)
SIC
Services-Health Services (8000)
akta.pro primary industry
Medication Safety, Dosing & Drug Interaction CDS (HLACAGAB)
akta.pro secondary industry
Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)

Keywords

  • AI dosing platform
  • Personalized medication dosing
  • Clinical decision support
  • Healthcare AI software
  • Drug dose optimization

Where Dosis is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Dosis business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Dosis product offering

Product offering

Core offering

Dosis sells an AI-powered personalized dosing platform intended for healthcare providers to determine individualized medication doses for patients. The platform replaces or augments standard dosing protocols with AI-driven, patient-specific dose recommendations as a clinical decision-support software tool.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dosis AI Personalized Dosing Platform An AI-powered software platform that provides personalized, patient-specific medication dose recommendations to healthcare providers, supporting clinical decision-making in drug dosing.

Companies that use Dosis

Customer profile

Ideal customer profiles1 record

Dosis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Dosis partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Dosis competitors and assessment

Company assessment

Emerging players

  • Arine: Arine applies AI to medication optimization and adherence for value-based care populations. It overlaps with Dosis on data-driven medication management but operates at the regimen/therapy level rather than per-dose decision support.
  • Renalytix: Renalytix applies AI-driven diagnostics and prognostic tools to kidney disease, overlapping with Dosis on the CKD patient population and value-based nephrology contracting — though Renalytix focuses on risk prediction rather than dosing.

Others

  • Health Catalyst: Health Catalyst is a healthcare data and analytics platform that increasingly embeds clinical improvement applications, including medication-related use cases. It is an adjacent data/analytics peer rather than a direct dosing competitor.
  • First Databank (FDB): FDB supplies drug knowledge bases (including dosing and interaction data) that power EHRs and CDS systems worldwide. It is an ecosystem enabler and indirect competitor whose content underpins many dosing workflows Dosis targets.
  • Wolters Kluwer (Medi-Span / UpToDate Lexidrug): Wolters Kluwer provides clinical drug information, including dosing guidance, integrated into provider workflows. It is an enabling/adjacent player whose dosing content competes for the same evidence-based decision moment.

Direct peers

  • DoseMe: DoseMeRx (formerly DoseMe) provides Bayesian-model-based individualized dosing software for hospitals and pharmacists, targeting similar therapeutic areas (e.g., vancomycin, aminoglycosides). It directly competes with Dosis's personalized dosing proposition.
  • InsightRX: InsightRX is a precision-dosing clinical decision support platform that uses Bayesian and ML models to individualize drug dosing for clinicians. It is the closest direct competitor to Dosis in AI-driven personalized dosing.

Broad incumbents

  • Tabula Rasa HealthCare: Tabula Rasa (now part of ExactCare) combines proprietary pharmacogenomics and dosing science with pharmacy services to optimize medication regimens for at-risk patients. It is a broader, more established incumbent in medication safety and dosing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Dosis social profiles

Digital presence

Dosis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dosis leadership team

Management profile

Number of profiles

Profiles3 records

Dosis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dosis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dosis

What does Dosis do?

Dosis sells an AI-powered personalized dosing platform intended for healthcare providers to determine individualized medication doses for patients. The platform replaces or augments standard dosing protocols with AI-driven, patient-specific dose recommendations as a clinical decision-support software tool.

When was Dosis founded?

Dosis was founded in 2017. It employs 1 to 10 people.

Where is Dosis based?

Dosis is headquartered in San Francisco, United States, in the North America region.

Who are Dosis's main competitors?

Emerging players on record are Arine and Renalytix. Others are Health Catalyst, First Databank (FDB) and Wolters Kluwer (Medi-Span / UpToDate Lexidrug). Direct peers are DoseMe and InsightRX. Tabula Rasa HealthCare is listed as a broad incumbent.

Does Dosis have an API?

No public API is recorded for Dosis.

What industry is Dosis in?

Dosis's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAGAB, Medication Safety, Dosing & Drug Interaction CDS, with a secondary code of HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools. Its NAICS code is 6219 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales